Inventor · disambiguated record
Roland D. Saito
Also filed as: SAITO ROLAND D
18 granted patents·12 pending applications·215 citations·filing 2014–2025
94Inventor score
Top patents by PatentIndex Score
30 records- 0198US11753399B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2022·Granted Sep 12, 2023·7 cites·31 claims
- 0298US10947259B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Granted Mar 16, 2021·11 cites·4 claims
- 0397US11325930B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted May 10, 2022·8 cites·4 claims
- 0497US11267801B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2020·Granted Mar 8, 2022·4 cites·23 claims
- 0597US10654827B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2018·Granted May 19, 2020·24 cites·15 claims
- 0697US10071985B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2017·Granted Sep 11, 2018·43 cites·25 claims
- 0797US9951043B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2014·Granted Apr 24, 2018·36 cites·34 claims
- 0897US9873680B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2015·Granted Jan 23, 2018·26 cites·40 claims
- 0996US10836746B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2019·Granted Nov 17, 2020·20 cites·26 claims
- 1095US11878965B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted Jan 23, 2024·4 cites·20 claims
- 1193US11993583B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2019·Granted May 28, 2024·3 cites·3 claims
- 1293US11976083B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted May 7, 2024·3 cites·15 claims
- 1391US10577352B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Granted Mar 3, 2020·10 cites·20 claims
- 1491US10059695B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Aug 28, 2018·12 cites·28 claims
- 1589US12398160B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Granted Aug 26, 2025·0 cites·2 claims
- 1688US2025333428A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1784US2025179102A1Therapeutics compounds for hiv virus infectionGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1883US11827662B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2022·Granted Nov 28, 2023·0 cites·2 claims
- 1983US10442804B2Compounds for the treatment of hepatitis B virus infectionGILEAD SCIENCES INC·Filed 2018·Granted Oct 15, 2019·4 cites·20 claims
- 2083US2024376077A1Therapeutic compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2182US2024067629A1Therapeutic compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2273US2021061831A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 2373US2022259234A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 2467US2024382474A1Enpp1 modulators and uses thereofVIR BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 2565US2021009555A1Therapeutic compoundsGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 2664US2018273508A1Therapeutic compoundsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2762US2023183188A1Enpp1 modulators and uses thereofVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 2858US12240862B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted Mar 4, 2025·0 cites·12 claims
- 2953US2024174702A1Solid forms of a compound for modulating cotGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3039US2017342068A1Compounds for the treatment of hepatitis b virus infectionGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roland D. Saito files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →